- Previous Close
28.50 - Open
28.50 - Bid --
- Ask --
- Day's Range
28.15 - 29.05 - 52 Week Range
25.00 - 35.85 - Volume
11,004 - Avg. Volume
17,708 - Market Cap (intraday)
1.234B - Beta (5Y Monthly) -0.28
- PE Ratio (TTM)
120.83 - EPS (TTM)
0.24 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 26, 2021
- 1y Target Est
--
Ma Kuang Healthcare Holding Limited, an investment holding company, provides medical services in Taiwan and internationally. The company offers community medical services, Chinese medical services, Chinese medicines, medical management training courses, educational support services, etc. It also provides medical treatment, and overseas student homestay and guardianship services; management consultant services; Chinese medicine beauty services; consulting services, such as corporate management, computer technology, industry information, and marketing; and e-commerce sales services. In addition, the company operates clinics, educational institutions, community medicine clinics, and traditional Chinese medicine clinics. Further, it is involved in sale of dietary supplement, and pharmaceutical and medical goods in stores; restaurant business; and lease and other services. The company was incorporated in 2009 and is based in Kaohsiung, Taiwan.
www.mk-healthcare.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 4139.TWO
View MorePerformance Overview: 4139.TWO
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4139.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4139.TWO
View MoreValuation Measures
Market Cap
1.21B
Enterprise Value
1.85B
Trailing P/E
118.75
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.08
Price/Book (mrq)
2.64
Enterprise Value/Revenue
1.64
Enterprise Value/EBITDA
6.82
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.70%
Return on Assets (ttm)
0.24%
Return on Equity (ttm)
-5.90%
Revenue (ttm)
1.16B
Net Income Avi to Common (ttm)
-19.6M
Diluted EPS (ttm)
0.24
Balance Sheet and Cash Flow
Total Cash (mrq)
65.88M
Total Debt/Equity (mrq)
158.62%
Levered Free Cash Flow (ttm)
239.02M